Skip to content
Menu

Lakefront Biotherapeutics NV LKFT

Full chart Compare
Set alert

Price alert · LKFT

All alert types
34.79 USD +0.81 (+2.38%)

Regular-session close

34.79 0.00 0.00%

After hours · Nov 16, 4:00 PM ET

34.45 Day range 35.15
25.68 52-week range 36.24
YTD
+6.39%
1 year
+11.19%

Revenue & Expenses

Revenue Profit Costs
Income Tax Benefit$18.62MGross Profit$1.08BCost of Revenue$29.74MGross Profit & Other Income$1.10BNet Income$320.88MSelling, General & Admin$111.96MResearch & Development$459.42MOther Operating Expenses$9.74MInterest Expense$2.22MOther Expenses$196.91MRevenue$1.11B

Latest period ending Dec 31, 2025 · select a line to chart its full history

LKFT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.11B275.65M239.72M241.25M234.38M
1.08B240.79M239.72M241.25M234.38M
295.04M-188.34M-88.26M-131.06M-171.57M
320.88M74.08M211.70M-217.99M-103.23M
4.871.123.21-3.32-1.58
LKFT annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
87.87M64.24M166.80M508.12M2.23B
3.41B4.14B4.36B4.73B5.19B
170.65M1.24B1.56B2.21B2.55B
6.92M11.72M9.60M21.90M26.86M
3.24B2.90B2.80B2.53B2.64B
LKFT annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-307.90M-417.26M-463.90M-488.49M-493.52M
288.81M220.60M71.19M-1.25B541.24M
-3.27M-4.92M-5.00M-1.49M-3.88M
-13.40M-82.11M-16.85M-36.21M-57.88M
28.09M-104.35M-339.79M-1.75B33.53M